



by H. V. Malling
The primary objective of the Institute's program
in mutagenesis is focused on evaluation and defini-
tion of risks to both human somatic and germinal
tissue resulting from exposure to genetically active
environmental chemicals. The Laboratory of En-
vironmental Mutagenesis was organized late in FY
1972. Because of the worldwide shortage of re-
sources for the rapid development of research in
various problem areas associated with environmen-
tal mutagenesis, staff members have used a variety
of approaches to accomplish its objective. These
include:
(1) Development of an intramural research pro-
gram divided into eight main areas. Work on particu-
lar projects has been carried out by different
mechanisms: in-house research by staff scientists,
support of work at other institutions in the col-
laborative research program with staff scientists as
project officers, and developing an announcement
in collaboration with the extramural program office
to solicit grant proposals in specific emphasis areas
of environmental mutagenesis.
(2) Development of a coordinated national
program in environmental mutagenesis. A variety of
mechanisms have been initiated, including: partici-
pation in the DHEW Subcommittee on Environ-
mental Mutagenesis (SEM), developing workshops
and conferences in special emphasis areas, develop-
ing collaborative programs with other institutes
within NIH and with other agencies, developing
programs within the Environmental Mutagen Soci-
ety in which staff members serve as officers, coun-
cillors, or members, and developing collaborative
studies on genetically active environmental chemi-
cals to rapidly develop a data base to assist in
evaluating the risk of exposure to man.
(3) Development of better communication and
coordination at the international level. Staff mem-
bers are associated with several international pro-
grams, including a U.S.-U.S.S.R. Environmental
Protection Agreement, participation in interna-
tional workshops and conferences, collaboration
with IARC (Lyon) on the mutagenicity ofchemical
carcinogens.
(4) Development of better mechanisms for infor-
mation exchange, including support of the En-
vironmental Mutagen Information Center (EMIC)
and serving as associate editor or members of the
editorial board on journals which publish research
in the area of environmental mutagenesis
(5) Development of better mechanisms for train-
ing young scientists for research careers in en-
vironmental mutagenesis at the predoctoral level
and the postdoctoral level.
Intramural Research Program
The intramural staff has been organized into
seven programs. The major research accomplish-
ments in each program are as follows:
The Microbial Genetics Section has made con-
siderable progress in the development and im-
provement of simple and comprehensive tests for
gene mutations and other types of genetic damage
in microorganisms. Dr. Zeiger has attempted to
correlate the mutagenicity of various procar-
cinogens using rat liver homogenate as activation
system with measurement ofthe enzyme activity in
the same aliquots. Together with Dr. Chhabra, he
also is trying to study the relationship between the
mutagenic activation in the intrasanguineous
host-mediated assay and activation in vitro using
bacteria as indicator organisms.
Drs. Frezza and Zeiger are using two different
yeasts in the intrasanguineous host-mediated assay.
Dr. Malling and Mr. Claxton have developed an
instant computerized data acquisition system for
the short-term testing of mutagenic activity.
Yeast is the only system for studying mitotic re-
combination. Unfortunately. rost yeast strains are
rather impermeable. Dr. Callen is using crystal vio-
let to isolate more permeable strains ofyeast. He is
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compounds by ultraviolet irradiation of fuel oil on
top of water.
Dr. Scott has been working especially on de-
veloping a system inAsper-gillus nidulans for detec-
tion of 50 plus genetic events. These events range
from point mutations, chromosome aberrations,
and mitotic recombination. Dr. Scott has tried also
to develop Salmonella typhimurium, E. coli,
Neurospora crassa, and Aspergillus nidulans.
None of these systems are as sensitive as Trades-
cantia.
Mr. Harvey has studied the tritiated water as a
mutagen in the ad-3 mutation system.
Dr. Ong has developed a spot test system for
detecting reverse mutations at the ad-3 locus of
Neuirospora crassa. Various tester strains have
been selected that exhibit sensitivity to various
types of chemical mutagens. This rapid assay will
complement the ad-3 forward mutation system ear-
lier developed by Dr. de Serres which has been
used by Drs. Ong and de Serres to test the
mutagenicity of several chemical carcinogens and a
wide variety of environmental chemicals. These
studies are designed primarily as structure-function
analyses to determine the correlation between types
ofgenetic damage induced by compounds ofsimilar
structure. Many chemicals do not exert
mutagenesis by themselves but can be converted to
mutagenic metabolites. Drs. Whong and Ong are
using the ad-3 system to study the activation of di-
methylnitrosamine to mutagens in the host-
mediated assay and are comparing the results from
different tissues and species.
Drs. de Serres, Ong, and Inoue also are continu-
ing studies on repair-deficient strains of Neuro-
spora. In a comparison between the normal
heterokaryon and one homozygotic for repair-
deficient mutants for five mutagens, it was found
that they all caused more killing in the repairless
strains than in the normal strain, but only those
chemicals which react covalently with the DNA.
Mr. Harvey also has extended the study on the re-
pairless mutants in Neurospora and has shown that
upr-I and ius-2 are not in the same pathway of re-
pair.
Drs. Maier, Chhabra, and Mailing have focused
their attention on the activation systems which
occur in the testicular cells and found that nitro-
furazones are activated to mutagenic metabolifes.
Great progress has been made within the Mam-
malian Biochemical Mutagenesis Program, where
Dr. Soares was able to isolate biochemical muta-
tions in mice using the biochemical specific locus
mutation system. Dr. Soares used TEM as a model
mutagen and has isolated more than 10 mutants.
Dr. Valcovic has continued the study of the
6"Co-induced biochemical mutants. This mutation
system will be expanded in the future to cover many
more parameters. Dr. Lee is working on a system
for detection ofheat-instability mutations and muta-
tions which affect specific activity ofenzymes. Mr.
Burkhart is developing the techniques and computer
programs for the high speed centrifugal enzyme
kinetic analyzer (MCFA). In order to understand
the limitations of these techniques, Dr. Pegoraro is
studying the naturally occurring polymorphic en-
zymes in mice.
The Biochemical Genetics Group is new and is a
very important addition to the Laboratory of En-
vironmental Mutagenesis. The group will study the
enzymes and mutant enzymes in detail in order to
elucidate the molecular mechanism of mutagenesis
in mammals. Dr. Li will characterize the various
isozymes and mutant proteins and correlate the
amino acid differences and antigenic determinants
oflactic dehydrogenase in mammals. Dr. Marcinis-
zyn will concentrate on the sperm-specific lactate
dehydrogenase in mammals, and Dr. Chen will
characterize the mutant proteins from mammalian
somatic cells.
The studies within the mammalian genetics
program are concerned primarily with the detection
ofinduced genetic damage in mice, investigations of
the transmissibility of the damage to the progeny,
and the long-term effect of mutations and
chromosomal aberrations on the development of
the embryo.
Drs. Sheridan and Soares are comparing the in-
duction ofdominant lethal mutations and transloca-
tions induced in a wide variety of inbred strains of
mice after treatment with a given dose of
triethylenemelamine. The objective of this work is
to develop a battery of tester strains ranging from
very sensitive to very resistant which will better
mimic the range of variation that we can expect in
the heterogeneous human population. They also are
studying the induction of recessive lethal by chemi-
cal mutagens. This is an especially important study,
since it can be assumed that each human carries five
or six recessive lethal mutations, and not much is
known about their effect on fitness of the indi-
vidual. In order to study the apparent lack of re-
sponse of mouse spermatogonial stem cells to
mutagenic treatment, Drs. Sheridan and Soares
have used combined treatments of radiation and
chemical mutagens and are investigating whether or
not pretreatment with irradiation will sensitize
spermatogonia to induction of mutations by chemi-
cals.
A study to detect induced genetic changes in both
somatic and germ cells is being carried on by Drs.
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from chemically treated males are being examined
for chromosomal aberrations. The aim of this ap-
proach is to use somatic cell mutagenesis as a pre-
dictor for germ cell effects. The success of this
program could greatly reduce the cost and time of
mammalian mutagenicity testing.
Drs. Burki and Sheridan have studied chromo-
some aberrations in early mouse embryos after
mutagenic treatment of parents. While dominant
lethal effects have been induced by several chemi-
cals, the genetic causes have not been elucidated.
This research seeks to determine the relative con-
tribution ofchromosome aberrations to this class of
dominant lethal events.
Drs. Michelmann and Sheridan have studied the
effect and unbalanced genomes on the development
of the early embryos. These studies are especially
important for understanding Down's Syndrome in
humans.
In the Somatic Cell Genetics Group, the
mechanism for induction of mutations in mam-
malian cells in vivo and in vitro are being sought.
Drs. Nialling and Ansari are utilizing the various
hemoglobins of the inbred strains of mice which
differ in as many as nine amino acids. Attempts to
produce specific antibodies to these variant hemo-
globins are carried out. The antibodies will be cou-
pled with fluorescent molecules. Using these
labeled antibodies, mutations can be detected in red
blood cells. Other systems are being developed by
Dr. Malling which are based on detection of muta-
tions in sperm specific enzymes using histochemical
techniques. At the present time we have developed
histochemical stains for succinyl dehydrogenase,
a-glycerolphosphate dehydrogenase, and lactic acid
dehydiogenase and have found two inhibitors for
the first and last enzyme. Mr. Dix is attempting to
develop an automatic screening system for detec-
tion of these variant cells down to the level of 10-6.
Dr. Huang is developing a gene mutation detec-
tion system in human diploid fibroblasts. Forward
mutations will be detected at a sex-linked locus
(HGPRT) and an autosomal locus (AGPRT). At
the same time he is measuring the amount ofadduct
formed after reaction of the mutagen with the
DNA. This will quantitatively give the efficiency of
the chemical as a mutagen. Dr. Huang also is study-
ing the effect of particular matter such as asbestos
on cell death and mutation induction and has found
that the toxicity is directly related to the amount of
phagocytosis. In order to better understand the mu-
tation expression, he is correlating the thioguanine
resistant mutation frequency with the half-life of
HGPRT in the cells.
A predominant part ofthe effort within the Popu-
lation Genetics Program concerns itself with de-
termination ofthe frequency ofnewly arisen genetic
variation and its effect on the fitness of natural
populations. In order to provide the background,
Dr. Voelker is studying naturally occurring alleles
ofenzyme loci which result in no enzyme activity at
all. To do this he has constructed a strain which is
heterozygotic at 22 loci.
Drs. Langley and Smith have extended this study
to see if there is any association among the various
biochemical polymorphism and the physiological or
developmental effect of these genes. They found
very little nonrandom association.
Drs. Langley and Shah have studied the variation
of the mitochondrial DNA within the species of
Drosophila; this will lead to a better understanding
of the role of the mitochondria DNA in the cellular
development.
The Mutagenesis Testing Program is a new func-
tion for LEM established by this year's budget,
which will be carried out under the collaborative
program and coordinated by Dr. Valcovic. While it
is not part of the intramural research program, it
can be considered to be an extension ofthe in-house
effort.
Until recently, mutagenicity testing was done on
preselected compounds in a manner in which the
testing laboratories knew the identity of the sub-
stances under test and the "expected" results, i.e.,
positive for compounds selected because of their
carcinogenicity and negative for food additives.
There is no completed study in which substances
were tested blind using a standardized protocol.
Also, little attention has been placed on reproduci-
bility and variability within and between lab-
oratories. These aspects are currently under in-
vestigation in microbial systems by NCI but the
results will not be available for 1-2 years.
In the N IEHS testing program a large number of
substances will be tested in a blind study. This will
involve the use of a hierarchy of tests proceeding
from rapid screening in simple, highly sensitive
microbial systems, through in vitro mammalian sys-
tems, up to whole mammal tests.
Collaborative Research Program
In the Collaborative Research Program, most of
the contracts fall naturally within five areas: (1) de-
velopment of systems for monitoring of the human
population for mutations, (2) development of risk
extrapolation systems to predict induced mutation
rate in the human population, (3) development of
short-term test systems fot mutagenicity, (4)
monitoring of the human environment for
mutagenic compounds, and (5) dissemination of
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Mutation Monitoring Systems
for the Human Population
In a contract at the University ofWashington, an
attempt is being made to develop a simple system to
measure point mutations in readily accessible
human somatic cells. This assay is based on
changes in the expected frequency of human red
blood cells containing hemoglobin S rather than
normal hemoglobin. Specific antiserum is being de-
veloped to detect mutations which produce hemo-
globin S. By conjugating the antiserum with dif-
ferent colored fluorescent dyes, mutant RBC's will
fluoresce.
Risk Extrapolation Systems
Recessive Lethal Mutations. In a contract at
The Jackson Laboratory, progress has been made
toward the development of a new mouse strain car-
rying multiple chromosome inversions to make it
possible to detect gene mutations (recessive lethal
mutations) in the chromosome regions covered by
the inversions. One of the 39 inversions thus far
recovered has been used in tests to detect x-ray
induced recessive lethal mutations to demonstrate
the general utility ofthis approach. Fourteen inver-
sions have been mapped and are now being com-
bined into a single mouse strain. Some of the com-
binations have lead to sterility.
Biochemical Mutations. A contract with The
Jackson Laboratory involves the incorporation of
13 additional mouse enzyme alleles into the
C57BL/6J strain. This will directly complement the
electrophoretic assay system developed at our In-
stitute and will significantly enhance the sensitivity
of the system to detect biochemical specific locus
mutations.
In a contract with Research Triangle Institute,
the progeny from treatment ofthe male parent with
TEM is presently being screened with a role of 800
mice per month. Many different types ofmutations,
such as esterase mutations, have been found.
Polygenic Mutations. A contract with the
Georgia Institute of Technology attempts to de-
velop a polygenic assay for the detection of point
mutations in mice. By studying changes in the
means and variances of characters determined by
many genes, it should be possible to detect g'enetic
changes which do not express major phenotypic ef-
fects.
Dietary Deficiency Effect on Mutation
Rate. In a contract with Knox College, studies
are being conducted in Drosophila melanogaster to
determine the effects of dietary deficiency on the
sensitivity to mutagenic treatment. Preliminary re-
sults have indicated that deficiencies in choline and
cholesterol increase the amount of genetic damage
observed following treatment.
Short-Term Tests for Mutagenicity
Computer System for Short-Term Tests. A
contract at New York Medical School attempts to
develop, in collaboration with DCRT in Washing-
ton, a computer system for assisting, advising, and
collecting the data from short-term tests. The sys-
tem is now working very well.
Testing ofNeurospora Mutants. We have con-
tinued to support a contract at Miles Laboratory to
perform the genetic analysis ofad-3 mutants recov-
ered from experiments on haploid strains of two-
component heterokaryons. During the past two
years we have also been using repair-deficient
strains of Neurospora, as the genetic characteriza-
tion performed in this manner has shown striking
qualitative differences between wild-type and exci-
sion repair-deficient strains.
Monitoring of the Human Environment for
Mutagenic Compounds
By interagency agreement, we are supporting
baseline studies to determine the mutagenicity of
airborne chemical pollutants and other gases used
by industry. Various clones of the plant
Tradescantia paludosa are being developed to
select one particularly sensitive clone for assays of
the genetic activity ofweak mutagens. Field studies
have been done in collaboration with NERC-EPA
to compare the effects of exposure to the same air-
borne pollutants under laboratory and field condi-
tions, and positive results have been obtained from
some heavily polluted areas.
Collection and Dissemination of
Mutagenesis Literature
During the past year we have continued to sup-
port EMIC (Environmental Mutagen Information
Center) by interagency agreement at the Oak Ridge
National Laboratory. This center has over 19,000
bibliographic entries in its data banks and contains
as a unique world-wide resource for information in
the area of environmental chemical mutagenesis.
National Programs
To develop better coordination in environmental
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tramural scientific staff in problem definition and
resolution in the rapidly developing field, a variety
of mechanisms have been developed.
SEM (DHEW Subcommittee on
Environmental Mutagenesis)
Intramural staffmembers have continued partici-
pation with at least 20-30 representatives from
DHEW and other government agencies to develop
better communication within DHEW as well as be-
tween other agencies with programs in environmen-
tal mutagenesis. The Panel meets monthly for dis-
cussion, and minutes are recorded to provide the
basis for furthering communication within the vari-
ous member institutes and agencies. A subcommit-
tee was formed of SEM to develop the gov-
ernment's general position on mutagenesis test-
ing. Dr. Valcovic served as Executive Secretary of
this group and Drs. Malling and Zeiger were work-
ing members. During the development of the
document, several open meetings were held at
NIH. The document was finally turned over to Dr.
Rall in April 1977. This is probably the most impor-
tant part of the SEM work in FY 1977.
Workshops and Conferences
In collaboration with The Jackson Laboratory in
Bar Harbor, Maine, Dr. Sheridan organized a
workshop to "Design New Methods for Assessing
Mutations in Mammalian Systems," which was
held on October 6-8, 1976. The proceedings will be
published in GENETICS.
Collaborative Programs with Other
Institutes within DHEW and with
Other Government Agencies
NCI. In collaboration with staff scientists at
NCI, a collaborative research program has been
persued to determine the correlation between car-
cinogenic and mutagenic activity of chemical car-
cinogens and non-carcinogenic structural analogs.
This has also involved development ofmechanisms
to review and evaluate performance ofthe contrac-
tors as well as the planning of workshops to
evaluate the accomplishments of the overall pro-
gram. In collaboration with staff members of the In
Vitro Carcinogenesis Program, new plans have
been made to validate microbial and mammalian
tests for mutagenicity for use as prescreens in the
carcinogenicity test program.
FDA. In collaboration with staff scientists in
the Bureau of Foods, NIEHS staff scientists have
participated in the successful development and re-
view ofcollaborative research programs to develop
common methods for screening and computerizing
data handling.
EPA. In collaboration with staffscientists in the
Office of Pesticide Program, NIEHS staff scien-
tists have participated in the development of col-
laborative research programs to perform mutagenic-
ity tests on pesticides.
NSF and OtherAgencies. Staff scientists have
participated in the review of proposals for contract
work and in site visits to select suitable contractors
for research in the area of mutagenicity testing.
International Program
Staff members are associated with a wide variety
of international programs with individual countries
as well as with international agencies and programs.
U.S.-U.S.S.R. Environmental Protection
Agreement
Drs. Langley and Valcovic visited several genet-
ic laboratories in the Soviet Union in September
1976 to discuss future collaboration under this
agreement. The fourth workshop on Basic and
Practical Approaches to Environmental Muta-
genesis and Carcinogenesis was held in San Fran-
cisco, California, in April 77. The program was
focused on research directed towards developing
better screening systems to detect mutagenic and
carcinogenic activity as well as methods suitable
forgenetic monitoring ofthe humanpopulation.
Collaboration with IARC (Lyon)
During FY 1977 a new program was continued
which involves participation between the National
Institute of Environmental Health Sciences staff
scientists, EMIC personnel and IARC scientists to
translate mutagenicity data of known chemical car-
cinogens. Staff members also are participating in a
series ofworkshops organized by the IARC staffto
evaluate the correlation between carcinogenic and
mutagenic activity and the possibility of using
short-term tests for mutagenic activity to predict
potential mutagenic and carcinogenic activity in
man.
U.S.-People's Republic of China
In connection with the expanded program of sci-
entific exchange with the People's Republic of
China, a Chinese delegation visited the Laboratory
of Environmental Mutagenesis in September 1976.
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Meetings
Dr. Malling participated in the meeting of the
German Environmental Mutagen Society, held July
1-2, 1976. The meeting of the International En-
vironmental Mutagen Society will be held in Edin-
burgh, Scotland, in July 1977; and Drs. Malling,
Valcovic, and Zeiger will participate. Dr. Malling
will be a lecturer at the EMBO Course in Mam-





The Institute has continued to support the work
of EMIC to collect, organize, and disseminate in-
formation on environmental chemical mutagens.
The Center not only processes requests for infor-
mation from various government agencies, but is
now becoming well known abroad. During the past
year, EMIC's data file reached 19,000 bibliographic
entries.
Journals
Staff members serve as associate editors, assis-
tant editors or members of editorial boards of Mu-
TATION RESEARCH, CANCER RESEARCH, ENVI-
RONMENTAL HEALTH PERSPECTIVES. JOURNAL
OF TOXICOLOGY, and, REVIEWS IN GENETIC
TOXICOLOGY. This makes it possible not only to
promote publication of papers dealing with various
research areas of environmental mutagenesis but
also to promote development of new methods for
publication.
Training Programs
The great shortage of scientists to do research in
the area of environmental mutagenesis both in the
United States and abroad has provided incentive
for staff scientists to develop a training program at
both the predoctoral and postdoctoral levels. Dur-
ing the past year, we have provided facilities for
research for three predoctoral students from the
University ofNorth Carolina at Chapel Hill. At the
postdoctoral level, staff scientists include 16 visit-
ing fellows from ten foreign countries.
In conclusion, during the past year we have been
successful in recruiting key personnel for our in-
tramural program, have continued cooperative
programs with other Laboratories in the Institute,
have coordinated program development of the
Laboratory with complementary programs in other
Federal agencies, and have established lines of
communication with newly developing scientific
organizations for environmental mutagenesis
abroad. Along with the organization of workshops
and conferences, these approaches will be used to
stimulate research and development in this rapidly
developing area of environmental health science.
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